Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Sophia Claire 2025 Sep 04, 10:10

Apple iPhone 17 Price Speculation & New Devices: A Closer Look at Projections

Ava Grace 2025 Sep 04, 05:10

Goldman Sachs: Gold Could Hit $5,000 if Fed Credibility Falters

Ghko B 2025 Sep 03, 16:00

PLTR Stock Prediction: Will Palantir Technologies Stock Keep Going Down?

stocks
Ghko B 2025 Sep 03, 16:00

The Vanguard S&P 500 ETF Is Up: How Is VOO Stock Doing?

etfs stocks
Ghko B 2025 Sep 03, 16:00

Cardano price prediction: How high can Cardano (ADA) price go in 2025?

crypto
Frances Wang 2025 Sep 03, 16:00

PLTR stock is going down: What to know about Palantir Technologies?

stocks
Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

2022 Jul 24, 05:42

Week ahead: Fed to hike 100bps into a recession?

Latest news

Show more
Ava Grace 2025 Sep 04, 13:20

US Labor Market Concerns Grow as ADP Data Disappoints and Jobless Claims Rise

Liam James 2025 Sep 04, 13:20

Milan Fed Nomination Hearing: Central Bank Independence Under Scrutiny

Sophia Claire 2025 Sep 04, 09:20

Foreign Exchange Markets' Risk Aversion Spikes Ahead of US Jobs Data

Ava Grace 2025 Sep 04, 08:20

Unlikely Alliance Emerges in Congress to Ban Stock Trading for Lawmakers

Ava Grace 2025 Sep 04, 07:20

UK Gilts: A Generational Buying Opportunity? Analyzing the Bond Market Surge

Ava Grace 2025 Sep 04, 06:20

Optimus Next Gen: A Glimpse at Tesla's New Gold Robot and Musk's Future Vision

Sophia Claire 2025 Sep 04, 06:20

European Nations Weigh Ukraine Security Pledges Amid Deployment Disagreements

Sophia Claire 2025 Sep 04, 05:20

EU-US Trade Agreement Revamp Threatens Fragile Truce, Sparks Concerns

Info

Spread

0.29

Spread (%)

0.6174 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

96683401216

Shares Outstanding

2035440000

Earnings Date (Next)

2001-08-07

Div Yield

2025-08-01

Ex-Dividend Date

2025-07-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.0523

EPS

2.49

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Sep 03, 16:00

Google shares jump: How to trade Alphabet (GOOG) stock CFDs?

Stocks
Frances Wang 2025 Sep 03, 16:00

What is iShares bitcoin Trust ETF IBIT: How to trade IBIT CFDs?

ETFs Crypto CFD Trading
Frances Wang 2025 Sep 03, 16:00

Crypto CFD Trading Brokers and Platforms: eToro, Plus500, BlackBull Markets

CFD Trading Crypto
Trustpilot